Gentex (GNTX) Research & Development (2009 - 2026)

Gentex (GNTX) has reported Research & Development for 18 consecutive years, with $49.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development fell 4.3% year-over-year to $49.3 million; the trailing twelve-month figure through Jun 2026 stood at $206.8 million (up 7.31% YoY), and the FY2025 full-year result was $203.3 million, up 12.0% from the prior year.
• Research & Development slipped to $49.3 million in Q2 2026 per GNTX's latest filing, from $51.7 million in the prior quarter.
• Across five years, Research & Development topped out at $53.2 million in Q4 2025 and bottomed at $32.0 million in Q1 2022.
• Historically, Research & Development has averaged $43.0 million across 5 years, with a median of $43.1 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Research & Development grew 21.72% in 2024, then dropped 4.3% in 2026.
• Over 5 years, Research & Development stood at $34.9 million in 2022, then advanced by 18.89% to $41.5 million in 2023, then rose by 13.31% to $47.1 million in 2024, then gained by 13.1% to $53.2 million in 2025, then retreated by 7.46% to $49.3 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $49.3 million, $51.7 million, and $53.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.